<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05623956</url>
  </required_header>
  <id_info>
    <org_study_id>N-20220023</org_study_id>
    <nct_id>NCT05623956</nct_id>
  </id_info>
  <brief_title>Proteomics in Small Cell Lung Cancer</brief_title>
  <acronym>SCLC-OMICS</acronym>
  <official_title>Circulating Metabolites and Tumor-derived Extravesicular Proteins in Small Cell Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aalborg University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aalborg University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to gather insight into tumor-derived circulating extracellular&#xD;
      vesicles-proteins in patients with newly diagnosed small cell lung cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will include 50 patients with newly diagnosed SCLC, referred to systemic&#xD;
      antineoplastic treatment at the Dept. of Oncology, Aalborg University Hospital and blood&#xD;
      samples from 50 healthy blood donors.&#xD;
&#xD;
      The blood samples from SCLC patients will be collected before chemotherapy with Carboplatin&#xD;
      and Etoposide and after 2 cycles of chemotherapy.&#xD;
&#xD;
      Imaging will be performed at the Dept. of Radiology, Aalborg University Hospital before&#xD;
      chemotherapy and after 3 cycles of the treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2023</start_date>
  <completion_date type="Anticipated">May 2025</completion_date>
  <primary_completion_date type="Anticipated">May 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identification and validation of protein biomarkers</measure>
    <time_frame>3 years</time_frame>
    <description>For identification and validation of protein biomarkers both untargeted and targeted proteomics will be performed, including a discovery-based bottom-up mass spectrometry approach and label-free Quantification Nano Liquid Chromatography Tandem Mass Spectrometry (LFQ nLC-MS/MS), enzyme-linked immunosorbent assay (ELISA)-based proteomics, and Western Blot analyses.</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Small Cell Lung Cancer</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study will include 50 patients with newly diagnosed SCLC, referred to systemic&#xD;
        antineoplastic treatment at the Dept. of Oncology, Aalborg University Hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written and signed informed consent&#xD;
&#xD;
          -  Histopathologically and/or cytologically newly-diagnosed SCLC&#xD;
&#xD;
          -  Measurable disease on CT scans&#xD;
&#xD;
          -  Eligibility to receive standard chemotherapy consisting of carboplatin and etoposide&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active biopsy-verified second malignancy other than non-melanoma skin cancer or&#xD;
             cervical carcinoma in situ&#xD;
&#xD;
          -  Prior treatment for any malignant diseases other than non-melanoma skin cancer and&#xD;
             cervical carcinoma in situ&#xD;
&#xD;
          -  Concomitant anticoagulation treatment (acetylsalicylic acid and clopidogrel are&#xD;
             allowed)&#xD;
&#xD;
          -  Treatment with any other investigational agent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Weronika Szejniuk, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aalborg University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Borgen Dalsgaard</last_name>
    <phone>97606989</phone>
    <email>anbd@rn.dk</email>
  </overall_contact>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 14, 2022</study_first_submitted>
  <study_first_submitted_qc>November 14, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2022</study_first_posted>
  <last_update_submitted>November 14, 2022</last_update_submitted>
  <last_update_submitted_qc>November 14, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aalborg University Hospital</investigator_affiliation>
    <investigator_full_name>Weronika Maria Szejniuk</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Proteomics</keyword>
  <keyword>Biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Small Cell Lung Carcinoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

